Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Results
Phase 2
This trial was for people with m and also for people with acute myeloid leukaemia (AML) who between them had 2 and 3 out of 10 blood cells (20 to 30%) that were immature.
Cancer Research UK supported this trial.
Recruitment start: 22 September 2010
Recruitment end: 30 September 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Ghulam Mufti
Cancer Research UK
Janssen-Cilag
King's College London
Kings College Hospital NHS Foundation Trust
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKE/09/040.
Last reviewed: 15 February 2017
CRUK internal database number: 2858
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
